The Bioinformatics Market size is estimated to grow from USD 10,220 Million in 2020 to USD 27,518 Million by 2027, growing at a CAGR of 15.2% during the forecast year from 2021 to 2027.
The “Bioinformatics – Market Analysis, Trends, and Forecasts 2021-2027 ” Study has been added to MarketDigits Market Research offering. The study focus on both qualitative as well as quantitative side and follows Industry benchmark and NAICS standards to built coverage of players for final compilation of study. Some of the major and emerging players profiled are Illumina Inc., Thermo Fischer Scientific (Life Technologies), Qiagen NV, Agilent Technologies, PerkinElmer, ABM, Dassault Systèmes, Geneva Bioinformatics SA, Ontoforce, Data4Cure, and Lineage Cell Therapeutics.
Request for Sample Copy of This Report @ https://marketdigits.com/bioinformatics-market/sample/
Scroll down 100s of data Tables, charts and graphs spread through Pages and in-depth Table of Content on “Bioinformatics Market, By Product (Sequence Analysis, Sequencing, Generalized), Sector (Medical Bioinformatics, Animal Bioinformatics, Academics), Application (Metabolomics, Transcriptomics, Proteomics) & Geography – Global Forecast to 2027”. Early buyers will get 10% customization on study.
To Avail deep insights of Bioinformatics Market Size, competition landscape is provided i.e. Revenue Analysis (M $US) by Company (2019-2021), Segment Revenue Market Share (%) by Players (2019-2021) and further a qualitative analysis is made towards market concentration rate, product/service differences, new entrants and the technological trends in future.
Unlock new opportunities in Bioinformatics Market; the latest release from MarketDigits highlights the key market trends significant to the growth prospects, Let us know if any specific players or list of players needs to consider to gain better insights.
Purchase Full Report @ https://marketdigits.com/bioinformatics-market/buy/
The bioinformatics market size is estimated to grow from USD 10,220 Million in 2020 to USD 27,518 Million by 2027, growing at a CAGR of 15.2% during the forecast year from 2021 to 2027. The research covers the current and historic bioinformatics market size and its growth trend with company outline of Key players/manufacturers: Illumina Inc., Thermo Fischer Scientific (Life Technologies), Qiagen NV, Agilent Technologies, PerkinElmer, ABM, Dassault Systèmes, Geneva Bioinformatics SA, Ontoforce, Data4Cure, and Lineage Cell Therapeutics (BioTime Inc.) among others.
Growth of the bioinformatics market is driven by the growing demand for nucleic acid and protein sequencing, increasing government initiatives and funding, and increasing use of bioinformatics in drug discovery and biomarker development processes. With the introduction of upcoming technologies such as nanopore sequencing (third generation sequencing technique) and cloud computing, the market is expected to offer significant opportunities for manufacturers of bioinformatics solutions. However, factors such as a dearth of skilled personnel to ensure proper use of bioinformatics tools and lack of integration of a wide variety of data generated through various bioinformatics platforms are hindering market growth.
By Product and Services, bioinformatics platforms segment is expected to be the fastest-growing segment in the forecast period
Knowledge management tools commanded the largest market share in the global bioinformatics market in 2018, while the bioinformatics platforms segment is expected to be the fastest-growing segment in the forecast period. The major factor driving growth of bioinformatics platforms is their growing use in various genomic applications. In addition, the use of bioinformatics platforms is increasing in the drug discovery & development process, which is contributing to market growth. However, the lack of standardization in bioinformatics platforms across the industry is restraining growth of the bioinformatics platforms market, owing to which bioinformatics professionals have to work with varying standards and platforms that give no reproducible results
By Application, the metabolomics segment is expected to grow at the highest CAGR during the forecast period
Factors such as the availability of research funding and government support are fueling market growth. However, metabolomes cannot be easily identified or figured from reconstructed biochemical pathways due to enzymatic diversity, substrate ambiguity, and difference in regulatory mechanisms. Hence, the annotation of unknown metabolic signals is the main hindrance to growth of the metabolomics segment.
By Sector, medical biotechnology segment is expected to grow at the highest CAGR during the forecast period
Various pharmaceutical companies are increasingly adopting bioinformatics tools to decrease the cost and time involved in drug discovery. Bioinformatics approaches for target discovery and validation are proving more efficient than traditional methods. With the help of bioinformatics tools, much of the information regarding drug candidates is validated at a molecular level, which tends to reduce drug attrition rate in the later stages of drug development. Thus, contributing to the success of more drug candidates in the clinical trials is making the drug development process more cost effective.
Pharma companies are also using AI along with bioinformatics tools to identify drug targets. Merck entered the AI space by collaborating with Numerate, Celgene partnered with GNS Healthcare, GSK collaborated with Exscientia, while Pfizer entered into a collaboration with IBM Watson for drug discovery research.
Bioinformatics in clinical diagnostics sector includes analysis of human genome with reference to disease diagnosis. This involves study of various omics technologies such as proteomics, metabolomics, metagenomics, epigenetics, and transcriptomics. Data generated through different omics technologies has assisted in the development of bioinformatics methodologies for clinical research and for building human databases. These computational approaches are then used to understand information about the origin, evolution, progression, and treatment of diseases, leading to the development of personalized medicine. Increased use of bioinformatics tools by clinicians also contributes to growth of the bioinformatics market. Rising use of bioinformatics tools is evident in the US, Europe, and parts of APAC. The APAC is expected to show highest CAGR while North America is expected to account for the largest share of the medical biotechnology market during the forecast period.
In 2018, The APAC market is expected to grow at the highest CAGR during the forecast period
The market in the Asia Pacific region is expected to offer significant opportunities for players to offset revenue losses incurred in mature markets. Emerging countries in this region are witnessing growth in their GDPs and a significant rise in disposable income levels. This has led to increased healthcare spending by a larger population base, healthcare infrastructure modernization, and rising penetration of cutting-edge research and clinical laboratory technologies, including bioinformatics, in Asia Pacific countries. These factors are expected to provide significant growth opportunities to bioinformatics companies operating in this region.
Driver: Growing demand for nucleic acid and protein sequencing due to reductions in sequencing costs and technological advancements
Bioinformatics is increasingly being used to identify genes in DNA sequences. The information collected is used to understand the molecular mechanisms of diseases. This assists in developing better treatments and diagnostic tests. Recently, due to significant reductions in costs of sequencing, many scientific research institutes and biotech companies have undertaken initiatives to perform sequencing studies at their own facilities. Similarly, sequencing and data analysis and interpretation can now be completed within days after the development of faster and sophisticated bioinformatics tools. With advancements in technology, there has been an increase in the speed of decoding genetic sequences, which has decreased the overall cost of sequencing and analysis per sample. The reasons behind this decrease in cost include the development of innovative DNA sequencing platforms and various bioinformatics tools.
Restraint: Lack of well-defined standards and common data formats for the integration of data
Standardization is crucial to ensure uniform and accurate results of samples for studies in healthcare. According to a social science research network, there is a lack of well-defined standards in bioinformatics, and because of this, every database or institute has its own exclusive identifiers, indexing schemes, data formats, and tools. In addition, as data models change frequently, the data integration process is often a significant challenge. Considering these factors, there is a need for standard bioinformatics infrastructure that can decrease data storage, increase data processing performance, and integrate diverse information.
Opportunities: IT giants investing in the development of bioinformatics solutions
IT giants have started focusing on bioinformatics for healthcare applications. Investments are being made for more advanced tests and techniques in battling diseases such as cancer and Parkinson’s. Microsoft co-founder Bill Gates and Amazon founder Jeff Bezos have invested millions of dollars in Grail, a start-up by gene sequencing firm Illumina that a former Google executive leads. Grail is developing a cancer-screening blood test for people, even if they show no symptoms. The test’s development is expected to require many samples to be sequenced and analyzed by using more comprehensive bioinformatics tools and databases.
Another IT giant, IBM, has introduced the IBM Watson for Genomics, which searches electronic medical databases to find information that may be relevant to a particular genomic sequence. IBM Watson’s beta version of Watson for Genomics is now commercially available for genomic data interpretation through partnerships with Quest Diagnostics, Illumina, or as a cloud-based software for clinicians and researchers. In 2018, Watson for Genomics was also used in clinical practice at the VA Health System, the largest integrated health system in the US. Similarly, in May 2018, IBM Watson for genomics was integrated with the Apollo chain of hospitals for the treatment of Cancer in India after results were found promising at the Manipal Hospital
Challenge: Shortage of skilled bioinformatics professionals
Globally, there is a huge demand for bioinformatics experts among companies operating in various sectors such as drug development, agriculture, and IT. Due to advancements in data generation techniques, a large amount of data is being generated per second, which is accumulating and is expected to become redundant. The number of skilled bioinformaticians is required to analyze data to reduce the gap. To cope with this issue, many companies are tying up with universities to hire the best talent in bioinformatics.
However, the industry is increasingly witnessing a dearth of skilled bioinformatics professionals. According to CSI-India, there is a severe shortage of bioinformatics professionals and molecular modeling experts at a global level. Similarly, as per the Institute of Bioinformatics and Applied Biotechnology (India), the cheminformatics field has a dearth of qualified bioinformatics professionals who can use computers and databases for chemical compounds or drug development. Most scientists at the forefront of experimental research lack bioinformatics expertise, which is a constraint in the full utilization of bioinformatics solutions in life science research.
Major Classifications are as follows:
- Sequence Analysis
- Manipulation, Alignment
- Structural & Functional Analysis Platforms
- Data Management
- Data Analysis Service
- Specialized Biocontent
- Medical Bioinformatics
- Animal Bioinformatics
- Agriculture Bioinformatics
- Molecular Phylogenetics
- Chemoinformatics & Drug design
All viewpoints in the report are based on iterative validation by engaging influencer, experts of the market, whose opinions supersede all other research methodologies. Both primary and secondary approach are used and detailed product portfolio / service offering were analysed and have been presented in a separate chapter of competitive landscape along with company profile.
Detailed Insights on Market Concentration Rate:
CR4, CR8 and HHI Index Analysis of Overall Market
Comparative Market Share Analysis (Y-o-Y)
Emerging Players – Heat Map Analysis
MarketDigits MR also offers Custom Research services providing focused, comprehensive and tailored research according to clientele objectives. Thanks for reading this article; you can also get individual chapter wise section or region wise report like North America, Europe or Asia.
Table of Contents
1 Market Overview
1.1 Global Bioinformatics Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by Regions
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1.1 Business Overview
2.1.2 Bioinformatics Type and Applications
2.1.3 Bioinformatics Sales, Price, Revenue, Gross Margin and Market Share (2021-2027)
3 Global Bioinformatics Market Competition, by Manufacturer
4 Global Bioinformatics Market Analysis by Regions
5 Region 1, Type, Application and Manufacturers
10 Global Bioinformatics Market Segment by Type
11 Bioinformatics Market Segment by Application
12 Bioinformatics Market Forecast (2021-2027)
13 Sales Channel, Distributors, Traders and Dealers
14 Research Findings and Conclusion
Any Questions? Inquire Here Before Buying @ https://marketdigits.com/bioinformatics-market/analyst/
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
USA : +1 847 450 0808
Email : [email protected]